These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1918170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The p53 tumor suppressor gene and gene product.
    Levine AJ.
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
    Thomas S, Reisman D.
    Cancer Lett; 2006 Aug 18; 240(1):48-59. PubMed ID: 16236433
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meth A fibrosarcoma cells express two transforming mutant p53 species.
    Eliyahu D, Goldfinger N, Pinhasi-Kimhi O, Shaulsky G, Skurnik Y, Arai N, Rotter V, Oren M.
    Oncogene; 1988 Sep 18; 3(3):313-21. PubMed ID: 3060794
    [Abstract] [Full Text] [Related]

  • 12. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL, Koeffler HP.
    Oncogene; 1994 Jul 18; 9(7):1899-906. PubMed ID: 8208536
    [Abstract] [Full Text] [Related]

  • 13. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D, Farr CJ, Marshall CJ.
    Oncogene; 1987 Jul 18; 1(4):409-13. PubMed ID: 3330783
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
    Richards CA, Short SA, Thorgeirsson SS, Huber BE.
    Cancer Res; 1990 Mar 01; 50(5):1521-7. PubMed ID: 2154325
    [Abstract] [Full Text] [Related]

  • 15. Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53.
    Loging WT, Reisman D.
    Cancer Epidemiol Biomarkers Prev; 1999 Nov 01; 8(11):1011-6. PubMed ID: 10566557
    [Abstract] [Full Text] [Related]

  • 16. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T, Reynolds S, Maronpot R, Anderson M.
    Cancer Res; 1990 Aug 01; 50(15):4818-23. PubMed ID: 2196119
    [Abstract] [Full Text] [Related]

  • 17. p53 transdominance but no gain of function in mouse brain tumor model.
    Hegi ME, Klein MA, Rüedi D, Chène P, Hamou MF, Aguzzi A.
    Cancer Res; 2000 Jun 01; 60(11):3019-24. PubMed ID: 10850451
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
    Oguey D, Dumenco LL, Pierce RH, Fausto N.
    Hepatology; 1996 Nov 01; 24(5):1024-33. PubMed ID: 8903370
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.